Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy
Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether 40 mg aprepitant administered before surgery
is effective for preventing vomiting in the first 24 hours after surgery in women undergoing
elective hysterectomy.